150 related articles for article (PubMed ID: 8452170)
21. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
Alanis A; Longest KA; Senetar JE; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of oral fleroxacin given once daily in patients with bone and joint infections.
Putz PA
Am J Med; 1993 Mar; 94(3A):177S-181S. PubMed ID: 8452177
[TBL] [Abstract][Full Text] [Related]
23. Randomized comparative study of fleroxacin and chloramphenicol in typhoid fever.
Arnold K; Hong CS; Nelwan R; Zavala-Trujillo I; Kadio A; Barros MA; de Garis S
Am J Med; 1993 Mar; 94(3A):195S-200S. PubMed ID: 8452180
[TBL] [Abstract][Full Text] [Related]
24. Systemic antimicrobial therapy for skin and skin structure infections: comparison of fleroxacin and ceftazidime.
Parish LC; Jungkind DL
Am J Med; 1993 Mar; 94(3A):166S-173S. PubMed ID: 8452175
[TBL] [Abstract][Full Text] [Related]
25. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
27. Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: a controlled clinical study.
Naber KG; Sigl G
Am J Med; 1993 Mar; 94(3A):114S-117S. PubMed ID: 8452166
[TBL] [Abstract][Full Text] [Related]
28. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
[TBL] [Abstract][Full Text] [Related]
29. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial.
Hopstaken RM; Nelemans P; Stobberingh EE; Muris JW; Rinkens PE; Dinant GJ
J Fam Pract; 2002 Apr; 51(4):329-36. PubMed ID: 11978255
[TBL] [Abstract][Full Text] [Related]
30. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial.
Clegg HW; Ryan AG; Dallas SD; Kaplan EL; Johnson DR; Norton HJ; Roddey OF; Martin ES; Swetenburg RL; Koonce EW; Felkner MM; Giftos PM
Pediatr Infect Dis J; 2006 Sep; 25(9):761-7. PubMed ID: 16940830
[TBL] [Abstract][Full Text] [Related]
31. A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection.
Gelfand MS; Simmons BP; Craft RB; Grogan J; Amarshi N
Am J Med; 1993 Mar; 94(3A):126S-130S. PubMed ID: 8452168
[TBL] [Abstract][Full Text] [Related]
32. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Henry DC; Kapral D; Busman TA; Paris MM
Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
[TBL] [Abstract][Full Text] [Related]
33. Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial.
Chuchalin AG; Berman B; Lehmacher W
Explore (NY); 2005 Nov; 1(6):437-45. PubMed ID: 16781588
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
35. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
[TBL] [Abstract][Full Text] [Related]
36. A randomised, prospective, single-blind comparison of cefadroxil and amoxycillin in the treatment of acute exacerbations of chronic bronchitis.
Bint AJ; Cefai C; McGhie D; Perera BS
Br J Clin Pract; 1989 Jan; 43(1):19-23. PubMed ID: 2686741
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of fleroxacin in the treatment of bone and joint infections.
Liu YC; Cheng DL; Liu CY; de Garis ST; Lin HH; Hsieh TL; Yen MY; Wang RS; Chen YS
Southeast Asian J Trop Med Public Health; 1992 Sep; 23(3):514-9. PubMed ID: 1488710
[TBL] [Abstract][Full Text] [Related]
38. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
39. Oral cefaclor for treatment of bronchitis--a comparative double-blind study versus amoxycillin.
Beumer HM; Veldkamp J
Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):113-7. PubMed ID: 7068283
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
Anzueto A; Fisher CL; Busman T; Olson CA
Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
